TRENDS IN THE RELEVANCE OF REAL WORLD EVIDENCE STUDIES IN THE GERMAN BENEFIT ASSESSMENT (AMNOG) PROCESS 2011-2019

被引：0
|
作者：
Borchert, K. [1 ]
Seidel, K. [1 ]
Loepmeier, J. F. [1 ]
Braun, S. [1 ]
Jacob, C. [1 ]
机构：
[1] Xcenda GmbH, Hannover, Germany
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PNS150
引用
收藏
页码：S666 / S666
页数：1
相关论文
共 33 条
  • [1] THE RELEVANCE OF REAL WORLD EVIDENCE STUDIES IN THE GERMAN BENEFIT ASSESSMENT (AMNOG) PROCESS
    Borchert, K.
    Loepmeier, J. F.
    Braun, S.
    Jacob, C.
    [J]. VALUE IN HEALTH, 2019, 22 : S795 - S795
  • [2] 10 YEARS OF AMNOG: IMPORTANCE OF REAL-WORLD EVIDENCE STUDIES IN THE GERMAN BENEFIT ASSESSMENT PROCESS
    Seidel, K.
    Schnaidt, S.
    Viering, T.
    Loepmeier, J. F.
    Borchert, K.
    Jacob, C.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S314 - S314
  • [3] RELEVANCE OF INDIRECT COMPARISONS IN THE GERMAN EARLY BENEFIT ASSESSMENT (AMNOG)
    Lebioda, A.
    Gasche, D.
    Dippel, F. W.
    Plantoer, S.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A484 - A485
  • [4] RELEVANCE OF REAL WORLD DATA IN GERMAN AMNOG SUBMISSIONS IN ONCOLOGY
    Haas, J. S.
    Borchert, K.
    Loepmeier, J.
    Braun, S.
    Mittendorf, T.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A469 - A469
  • [5] USE OF REAL WORLD EVIDENCE IN GERMAN AMNOG APPLICATIONS
    Altevers, J.
    Borchert, K.
    Mittendorf, T.
    Braun, S.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A95 - A95
  • [6] REAL WORLD EVIDENCE IN GERMAN HTA: THE CHALLENGES OF COMPARATIVE ROUTINE PRACTICE DATA COLLECTION (ABD) FOR EARLY BENEFIT ASSESSMENT (AMNOG)
    Bogner, K.
    Ebentheuer, L. M.
    Wegener, M.
    Wuetner, S.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S386 - S386
  • [7] INTRODUCTION TO THE AMNOG BENEFIT ASSESSMENT IN GERMANY AND ANALYSIS OF ITS OUTCOMES FROM 2011 TO 2019
    Feindt, W.
    Sauer, A. K.
    Eckert, N.
    Loepmeier, J. F.
    Kulp, W.
    [J]. VALUE IN HEALTH, 2020, 23 : S659 - S659
  • [8] Methods Used for Trend Estimation of Epidemiological Figures in the German Benefit Assessment (AMNOG) Process
    Schnaidt, S.
    Seidel, K.
    Viering, T.
    Loepmeier, J. F.
    Borchert, K.
    Jacob, C.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S336 - S336
  • [9] PREVALENCE AND INCIDENCE ESTIMATIONS IN GERMAN AMNOG APPLICATIONS - THE ROLE OF REAL-WORLD EVIDENCE (RWE)
    Altevers, J.
    Borchert, K.
    Mittendorf, T.
    Braun, S.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A558 - A558
  • [10] Trends in Collegiate Student-Athlete Mental Health in the National College Health Assessment, 2011-2019
    Edwards, Brian
    Froehle, Andrew W.
    Fagan, Siobhan E.
    [J]. JOURNAL OF ATHLETIC TRAINING, 2023, 58 (04) : 361 - 373
1234